Alnylam Pharmaceuticals, Inc. (ALNY)
| Previous close | 276.33 |
| Open | 275.39 |
| Bid | 273.52 x 100 |
| Ask | 274.46 x 200 |
| Day's range | 270.18 - 275.39 |
| 52-week range | 141.98 - 287.55 |
| Volume | |
| Avg. volume | 1,217,096 |
| Market cap | 35.178B |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.55 |
| Earnings date | 31 Oct 2024 - 04 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 286.65 |
Simply Wall St.High Growth Tech Stocks To Watch In September 2024
The market has climbed 1.0% in the last 7 days and is up 28% over the past 12 months, with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high-growth tech stocks can be crucial for investors looking to capitalize on robust market performance and strong future earnings potential.
Insider MonkeyAlnylam Pharmaceuticals, Inc. (ALNY): Hedge Funds Are Bullish on This Aggressive Growth Stock
We recently compiled a list of the 10 Best Aggressive Growth Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stands against the other aggressive growth stocks. If you’re putting money in the stock market, it’s more likely than not that growth […]
Simply Wall St.Three Stocks That Might Be Undervalued In September 2024
As global markets grapple with economic slowdown concerns, the S&P 500 Index has experienced its steepest weekly decline in 18 months, driven by fears of a weakening U.S. labor market and seasonal trading patterns. Despite these challenges, certain stocks may present opportunities for investors seeking undervalued assets amidst the turbulence. In this environment, identifying undervalued stocks involves looking for companies with strong fundamentals that are temporarily out of favor or...
